Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pearlman

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.
The Journal of Headache and Pain|August 29, 2021
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTANRichard B Lipton, Simin K Baygani, Stewart J Tepper, et al.
Cell Reports|June 25, 2020
Resolving Cell Cycle Speed in One Snapshot with a Live-Cell Fluorescent ReporterAnna E Eastman, Xinyue Chen, Xiao Hu, et al.
Biological Psychiatry|October 1, 2013
Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case reportSouhel Najjar, Daniel M Pearlman, Scott Hirsch, et al.
Cephalalgia : an International Journal of Headache|May 21, 2019
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failureDustin D Ruff, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
The Journal of Urology|February 12, 2013
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomyAlexander W Pastuszak, Amy M Pearlman, Win Shun Lai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapyN L Henry, R Xia, M Banerjee, et al.
Headache|February 20, 2026
Unmet treatment needs in migraine: Results of the OVERCOME (US) studySusan Hutchinson, Elizabeth Johnston, Robert A Nicholson, et al.
Cephalalgia : an International Journal of Headache|June 12, 2025
Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) studySait Ashina, Gilwan Kim, E Jolanda Muenzel, et al.
Journal of Medicinal Chemistry|June 1, 1987
Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acidsC J Blankley, J S Kaltenbronn, D E DeJohn, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.
The Journal of Headache and Pain|August 29, 2021
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTANRichard B Lipton, Simin K Baygani, Stewart J Tepper, et al.
Cell Reports|June 25, 2020
Resolving Cell Cycle Speed in One Snapshot with a Live-Cell Fluorescent ReporterAnna E Eastman, Xinyue Chen, Xiao Hu, et al.
Biological Psychiatry|October 1, 2013
Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case reportSouhel Najjar, Daniel M Pearlman, Scott Hirsch, et al.
Cephalalgia : an International Journal of Headache|May 21, 2019
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failureDustin D Ruff, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
The Journal of Urology|February 12, 2013
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomyAlexander W Pastuszak, Amy M Pearlman, Win Shun Lai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapyN L Henry, R Xia, M Banerjee, et al.
Headache|February 20, 2026
Unmet treatment needs in migraine: Results of the OVERCOME (US) studySusan Hutchinson, Elizabeth Johnston, Robert A Nicholson, et al.
Cephalalgia : an International Journal of Headache|June 12, 2025
Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) studySait Ashina, Gilwan Kim, E Jolanda Muenzel, et al.
Journal of Medicinal Chemistry|June 1, 1987
Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acidsC J Blankley, J S Kaltenbronn, D E DeJohn, et al.
Pageof 9